Mon, June 10, 2024

Swayampakula Ramakanth Reiterated (ALXO) at Strong Buy and Held Target at $25 on, Jun 10th, 2024

Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "ALX Oncology Holdings Inc." (ALXO) at Strong Buy and Held Target at $25 on, Jun 10th, 2024.

Swayampakula has made no other calls on ALXO in the last 4 months.



There are 3 other peers that have a rating on ALXO. Out of the 3 peers that are also analyzing ALXO, 1 agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Bradley Canino of "Stifel" Downgraded from Strong Buy to Hold and Increased Target to $14 on, Friday, March 8th, 2024


These are the ratings of the 2 analyists that currently disagree with Swayampakula


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, May 29th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $21 on, Friday, March 8th, 2024